Aliases & Classifications for Reading Disorder

MalaCards integrated aliases for Reading Disorder:

Name: Reading Disorder 12 15
Specific Reading Disorder 70 32
Developmental Reading Disorder 70
Dyslexia 70
Reading 17

Classifications:



External Ids:

Disease Ontology 12 DOID:13365
ICD9CM 34 315.09
ICD10 32 F81.0
UMLS 70 C0037789 C0154631 C0476254 more

Summaries for Reading Disorder

Disease Ontology : 12 A learning disability involing difficulty reading resulting primarily from neurological factors which affect any part of the reading process.

MalaCards based summary : Reading Disorder, also known as specific reading disorder, is related to dyslexia 2 and periventricular nodular heterotopia, and has symptoms including aprosodia An important gene associated with Reading Disorder is DCDC2 (Doublecortin Domain Containing 2). The drugs Levodopa and Acetylcysteine have been mentioned in the context of this disorder. Affiliated tissues include eye, breast and heart.

Wikipedia : 73 Dyslexia, also known as reading disorder, is characterized by trouble with reading despite normal... more...

Related Diseases for Reading Disorder

Diseases related to Reading Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 825)
# Related Disease Score Top Affiliating Genes
1 dyslexia 2 32.5 KIAA0319 DCDC2
2 periventricular nodular heterotopia 31.6 ROBO1 KIAA0319L KIAA0319 DNAAF4 DCDC2 CMIP
3 dysgraphia 31.0 KIAA0319 DNAAF4 DCDC2 CEBPD
4 stuttering 30.7 FOXP2 CNTNAP2 CMIP ATP2C2
5 attention deficit-hyperactivity disorder 30.7 KIAA0319 GRIN2B FOXP2 DCDC2 CNTNAP2
6 autism spectrum disorder 30.7 GRIN2B FOXP2 DOCK4 DNAAF4 DIP2A CNTNAP2
7 developmental coordination disorder 30.3 CEBPD ATP2C2
8 childhood apraxia of speech 30.2 FOXP2 CNTNAP2
9 amusia 30.1 DCDC2 ACOT13
10 dyslexia 30.0 TDP2 ROBO1 NRSN1 MRPL19 KIAA0319L KIAA0319
11 writing disorder 30.0 KIAA0319 DNAAF4 DCDC2 CEBPD
12 articulation disorder 29.9 FOXP2 CNTNAP2 CMIP CEBPD ATP2C2
13 pervasive developmental disorder 29.9 GRIN2B FOXP2 CNTNAP2
14 dyscalculia 29.9 NRSN1 KIAA0319 DNAAF4 DCDC2 CFAP47
15 specific language impairment 29.9 ROBO1 MRPL19 KIAA0319 GCFC2 FOXP2 DNAAF4
16 anterograde amnesia 29.8 GRIN2B CNTNAP2
17 speech disorder 29.8 KIAA0319 GRIN2B FOXP2 CNTNAP2 CMIP CFAP47
18 speech and communication disorders 29.8 ROBO1 KIAA0319 GRIN2B GCFC2 FOXP2 DNAAF4
19 disease of mental health 29.8 ROBO1 KIAA0319 GRIN2B FOXP2 DNAAF4 DCDC2
20 echolalia 29.8 FOXP2 CNTNAP2 CEBPD
21 benign epilepsy with centrotemporal spikes 29.7 KIAA0319 GRIN2B GCFC2 FOXP2 DNAAF4 CNTNAP2
22 specific developmental disorder 29.4 KIAA0319 GRIN2B FOXP2 DNAAF4 DCDC2 CNTNAP2
23 learning disability 29.3 ROBO1 KIAA0319L KIAA0319 GCFC2 FOXP2 DNAAF4
24 hyperlexia 11.3
25 dyslexia 1 11.3
26 epilepsy, reading 11.2
27 macular degeneration, age-related, 1 11.2
28 presbyopia 11.1
29 farsightedness 11.1
30 hypertension, essential 11.1
31 myopia 10.9
32 macular dystrophy, retinal, 1, north carolina type 10.9
33 retinoschisis 1, x-linked, juvenile 10.9
34 vitelliform macular dystrophy 10.9
35 verbal auditory agnosia 10.9
36 hypogonadotropic hypogonadism 10.9
37 gerstmann syndrome 10.9
38 marie unna congenital hypotrichosis 10.9
39 alexia 10.9
40 alzheimer disease 10.9
41 cataract 10.9
42 developmental dyspraxia 10.9
43 retinitis pigmentosa 10.9
44 retinal disease 10.8
45 stargardt macular degeneration 10.8
46 motion sickness 10.8
47 flna-related periventricular nodular heterotopia 10.8
48 macular telangiectasia type 2 10.8
49 cone-rod dystrophy 2 10.8
50 digeorge syndrome 10.8

Graphical network of the top 20 diseases related to Reading Disorder:



Diseases related to Reading Disorder

Symptoms & Phenotypes for Reading Disorder

UMLS symptoms related to Reading Disorder:


aprosodia

Drugs & Therapeutics for Reading Disorder

Drugs for Reading Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 387)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Levodopa Approved Phase 4 59-92-7 6047
2
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
3
Dopamine Approved Phase 4 62-31-7, 51-61-6 681
4
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
5
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
6
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
7
Carbon monoxide Approved, Investigational Phase 4 630-08-0 281
8
Sulfadiazine Approved, Investigational, Vet_approved Phase 4 68-35-9 5215
9
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 2713 9552079
10
Silver sulfadiazine Approved, Vet_approved Phase 4 22199-08-2 441244
11
Nicotine Approved Phase 4 54-11-5 942 89594
12
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
13
Zinc Approved, Investigational Phase 4 7440-66-6 32051
14
Ranibizumab Approved Phase 4 347396-82-1 459903
15
Doxazosin Approved Phase 4 74191-85-8 3157
16
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
17
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
18
Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
19
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
20
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
21
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
22
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
23
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
24
Nifedipine Approved Phase 4 21829-25-4 4485
25
tannic acid Approved Phase 4 1401-55-4
26
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
27
Ephedrine Approved Phase 4 299-42-3 9294
28
Phenylephrine Approved Phase 4 59-42-7 6041
29
Pseudoephedrine Approved Phase 4 90-82-4 7028
30
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
31
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 68-26-8, 11103-57-4 445354
32
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
33 Dopamine agonists Phase 4
34 Antiparkinson Agents Phase 4
35 Antioxidants Phase 4
36 Antidotes Phase 4
37 Expectorants Phase 4
38 N-monoacetylcystine Phase 4
39 Dopamine Agents Phase 4
40 Central Nervous System Stimulants Phase 4
41 Dopamine Uptake Inhibitors Phase 4
42 Lisdexamfetamine Dimesylate Phase 4
43 Atomoxetine Hydrochloride Phase 4
44 adderall Phase 4
45 Chlorhexidine gluconate Phase 4
46 Nicotinic Agonists Phase 4
47 Cholinergic Agents Phase 4
48 Psychotropic Drugs Phase 4
49 Cytochrome P-450 Enzyme Inhibitors Phase 4
50 Isophane Insulin, Human Phase 4

Interventional clinical trials:

(show top 50) (show all 1337)
# Name Status NCT ID Phase Drugs
1 Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia) Unknown status NCT00111371 Phase 4 Levodopa
2 A Pilot Study for a Prospective, Randomized Controlled Trial of Techniques for Perioperative Analgesia for Live Liver Donors Unknown status NCT03393988 Phase 4 Fentanyl infusion;Dexmedetomidine
3 Propranolol Reactivation Mismatch (PRM) Treatment for PTSD: A Pilot Study Unknown status NCT03652922 Phase 4 Reactivation Mismatch
4 The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction Unknown status NCT03197103 Phase 4 N-Acetylcysteine (NAC)
5 The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading Completed NCT00733356 Phase 4 Vyvanse
6 A Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder. Completed NCT00191906 Phase 4 Atomoxetine Hydrochloride;placebo
7 Reading ICARD: Interventions for Children With Attention and Reading Disorders Completed NCT01133847 Phase 4 Methylphenidate;Mixed Salt Amphetamine;Atomoxetine;Guanfacine
8 Neurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tasks Pre- and Post-Atomoxetine Treatment Completed NCT00716274 Phase 4 Atomoxetine;Placebo
9 Assessing the Feasibility of Continuous Glucose Monitoring in Reimagine Primary Care Clinics Completed NCT04413578 Phase 4
10 Omega 3/6 Fatty Acids for Reading in Children: A Randomised, Double-blind, Placebo-controlled Trial in 9-year-old Mainstream Schoolchildren in Sweden Completed NCT02557477 Phase 4
11 Open-Label Treatment With Atomoxetine Hydrochloride in Child and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia Completed NCT00191048 Phase 4 Atomoxetine
12 A Double-Blind Placebo Controlled Study of Atomoxetine Hydrochloride for the Treatment of ADHD in Children and Adolescents With ADHD and Comorbid Dyslexia Completed NCT00607919 Phase 4 Atomoxetine;Placebo
13 Central Venous Catheter-Related Infection: A Prospective Randomized Double-Blind Study Completed NCT00533988 Phase 4
14 Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers Completed NCT02245308 Phase 4 Nicotine Patches;Nicotine rescue method;Bupropion
15 Evaluation of Unilateral Ultrasound Guided Paravertebral Block as Perioperative Analgesia For Lower Limb-Sparing Surgery In Adult Cancer Patients: A Prospective, Randomized, Controlled Study Completed NCT04396561 Phase 4 Paravertebral group (group P):
16 Effects of Interactive Video Game Cycling on Obese Adolescent Health Completed NCT00983970 Phase 4
17 Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking Completed NCT02995915 Phase 4 Bupropion
18 The Utility of Insulin Glargine (Lantus) Compared to NPH in Ethnic Minority Type 2 Diabetic Subjects Starting Insulin Therapy Completed NCT00686712 Phase 4 1- Insulin glargine QHS;2 - Insulin glargine QAM;3 - NPH insulin QHS
19 Project Magnify - A Comparison of Two Strategies (Large Print Versus Optical Aids) for Helping Visually Impaired Students Improve Reading Abilities Completed NCT00366392 Phase 4
20 Evaluation of ReAding Speed, Contrast Sensitivity, and Work Productivity in Working Individuals With Diabetic Macular Edema Following Treatment With Intravitreal Ranibizumab Completed NCT02107131 Phase 4 Intravitreal ranibizumab 0.3mg
21 The Effects of Controlling Morning Hypertension on Target Organ Damage With Adrenergic Blockers, Based on Self-Measured Morning Blood Pressure Readings Completed NCT00285519 Phase 4 Doxazosin (drug)
22 A Study to Evaluate the Improvement in Reader Accuracy When Using a Read Method That Incorporates Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Visual Interpretation of Amyvid Brain Scans Completed NCT02107599 Phase 4 Florbetapir (18F)
23 Evaluation of Reader Training Processes by Comparing Clinical Interpretations to Centralized Expert Reads Completed NCT02051790 Phase 4 florbetapir F 18
24 Computerized Cognitive Skills Training in Severe Mental Illness Completed NCT01036282 Phase 4
25 Media Use in Preschooler Study (MUPS) An Office Based Intervention to Improve Media Use in Preschool Children: a Randomized Controlled Trial Completed NCT00959309 Phase 4
26 TRIAGE-CRT Telemonitoring in Patients With Congestive Heart Failure and Indication of ICD-Cardiac Resynchronization Therapy Completed NCT00395642 Phase 4
27 Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia Completed NCT02420015 Phase 4 Nicotine replacement therapy;Bupropion
28 Sitagliptin for the Prevention and Treatment of Stress Hyperglycemia in Non-Diabetic Patients Undergoing Cardiac Surgery Completed NCT02443402 Phase 4 Sitagliptin;Placebo;Regular Human Insulin;Insulin glargine;Supplemental insulin (Insulin lispro);Supplemental insulin (Insulin aspart)
29 Making Ramadhan Fasting a Safer Experience With Technology Study Completed NCT02189135 Phase 4
30 A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients Who Have Undergone PhotoREfractive Keratectomy (PRK) Recruiting NCT04396990 Phase 4 Dextenza 0.4Mg Ophthalmic Insert;Topical Prednisolone
31 Diabetes Prevention With Lifestyle Intervention and Metformin Escalation Recruiting NCT03258723 Phase 4 Metformin
32 Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor Recruiting NCT04392375 Phase 4 Nifedipine 30 MG;Placebos
33 The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus:A Randomized Controlled Trial. Recruiting NCT03955107 Phase 4
34 Analgesic Efficacy of Ultrasound Guided Erector Spinae Plane Block Versus Fentanyl Infusion in Pediatric Patients Undergoing Aortic Coarcitectomy. a Randomized Controlled Study. Recruiting NCT04128540 Phase 4 Fentanyl
35 Randomised, Double-blind, Phase IV Study to Compare the Incidence of ECG Changes During Elective Caesarean Section Under Spinal Anaesthesia When Using Phenylephrine or Ephedrine Infusion to Maintain Baseline Systolic Blood Pressure Terminated NCT01243970 Phase 4 Phenylephrine;Ephedrine
36 Correlation Between Muscle Oxygenation and Skin Pigmentation Withdrawn NCT00747162 Phase 4
37 A Double-blind, Randomized, Parallel 2- Arm Study to Compare the Efficacy of Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes Who Are Receiving Background Standard-of-care Cardio-metabolic Therapy With Metformin, an Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker, and a Statin. Withdrawn NCT03640221 Phase 4 Ertugliflozin;Hydrochlorothiazide 12.5mg
38 The Pilot Study:Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes Withdrawn NCT00505882 Phase 4 Pramlintide;Glargine;Lispro;Aspart
39 The Contribution of a Speech Perception Intervention to the Prevention of Phonological Awareness Deficits in Children With Speech Sound Disorders Unknown status NCT00818428 Phase 2, Phase 3
40 Improving Search Strategy for Identifying Urgent Conditions on the Chest X-ray. (Original Title in French: Améliorer la stratégie de Recherche et l'Identification Des Conditions Urgentes Sur Une Radiographie Pulmonaire: Impact de l'Utilisation d'un Logiciel Interactif de Lecture systématique) Unknown status NCT01883570 Phase 3
41 A Comparative Wear Test of Two Adhesives on the Unilect ™ Biotab Short Term Monitoring Electrode Unknown status NCT01590368 Phase 3
42 Comparison of Full-Field Digital Mammography With Digital Breast Tomosynthesis Image Acquisition in Relation to Screening Call-Back Rate Unknown status NCT01236781 Phase 2, Phase 3
43 Effect of External Counter Pulsation on IschemicStroke (ECP-STROKE) Unknown status NCT03075137 Phase 3
44 Effect of External Counter Pulsation on Coronary Artery Disease (ECP-CAD) Unknown status NCT03075124 Phase 3
45 A Multi-centre, Randomised Controlled Trial of Early Goal-directed Therapy in Patients Presenting to the Emergency Department With Severe Sepsis in Australasia Unknown status NCT00975793 Phase 3
46 A Multicenter, Placebo Controlled Study to Evaluate the Efficacy of the Administration of Fibrinogen on Blood Product Requirements in Liver Transplantation Unknown status NCT01539057 Phase 3 Fibrinogen;Saline
47 Traumatic Brain Injury in Latin America: Lifespan Analysis Unknown status NCT01068522 Phase 3
48 Early Interventions for Children With Reading Problems Completed NCT00065832 Phase 3
49 A Randomized Clinical Trial of the Effectiveness of Base-in Prism Reading Glasses Vs. Placebo Reading Glasses for Symptomatic Convergence Insufficiency in Children Completed NCT00347581 Phase 3
50 Efficacy and Safety of Autologous Bone Marrow Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus Completed NCT01759823 Phase 2, Phase 3

Search NIH Clinical Center for Reading Disorder

Genetic Tests for Reading Disorder

Anatomical Context for Reading Disorder

MalaCards organs/tissues related to Reading Disorder:

40
Eye, Breast, Heart, Bone, Liver, Skin, Lung

Publications for Reading Disorder

Articles related to Reading Disorder:

(show top 50) (show all 251)
# Title Authors PMID Year
1
The association between anxiety and academic performance in children with reading disorder: A longitudinal cohort study. 61
33733531 2021
2
Dyslexia treatment studies: A systematic review and suggestions on testing treatment efficacy with small effects and small samples. 61
33694077 2021
3
[Missed opportunities: The new ICD-11 diagnostic guidelines for reading, spelling and calculation disorders]. 61
33666495 2021
4
Language difficulties are a shared risk factor for both reading disorder and mathematics disorder. 61
33126134 2021
5
Face recognition in developmental dyslexia: evidence for dissociation between faces and words. 61
33241970 2021
6
Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis. 61
32851461 2021
7
[Executive functions disorders in children with dyslexia]. 61
33728849 2021
8
Eye movement patterns in Iranian dyslexic children compared to non-dyslexic children. 61
33261980 2020
9
Neural correlates of cognitive control deficits in children with reading disorder. 61
30919230 2020
10
Misunderstandings about developmental dyslexia: a historical overview. 61
32922710 2020
11
Intellectual Profiles in Children With ADHD and Comorbid Learning and Motor Disorders. 61
25808309 2020
12
Comparing reading speeds for reading standardized single sentences and paragraphs in patients with maculopathy. 61
32585666 2020
13
Handwriting Delay in Dyslexia: Children at the End of Primary School Still Make Numerous Short Pauses When Producing Letters. 61
32036738 2020
14
Phonological memory problems are magnified in children from language minority homes when predicting reading disability. 61
31685053 2020
15
Fractal Characterization of Stochastic Series Fluctuations of Children with Reading Disorders. 61
32248886 2020
16
Assessment for familial pattern and association of polymorphisms in KIAA0319 gene with specific reading disorder in children from North India visiting a tertiary care centre: A case-control study. 61
31814229 2020
17
Effect of READ1 on latent profiles of reading disorder and comorbid attention and language impairment subtypes. 61
31411106 2020
18
[Developmental disorders of academic skills in children: the efficacy and safety of Tenoten for children in the multicenter double-blind placebo-controlled randomized study]. 61
33081444 2020
19
Spatial Network Connectivity and Spatial Reasoning Ability in Children with Nonverbal Learning Disability. 61
31953441 2020
20
Functional connectivity of the reading network is associated with prenatal polybrominated diphenyl ether concentrations in a community sample of 5 year-old children: A preliminary study. 61
31743804 2020
21
Decreased Functional Connectivity Between the Left Amygdala and Frontal Regions Interferes With Reading, Emotional, and Executive Functions in Children With Reading Difficulties. 61
32410968 2020
22
Pure Alexia: A Combined First-Person Account and Neuropsychological Investigation. 61
31800487 2019
23
Cognitive and Behavioural Weaknesses in Children with Reading Disorder and AD(H)D. 61
31645633 2019
24
How Does iReadMore Therapy Change the Reading Network of Patients with Central Alexia? 61
31085605 2019
25
Understanding comorbidity of learning disorders: task-dependent estimates of prevalence. 61
30144072 2019
26
What causes dyslexia? Identifying the causes and effective compensatory therapy. 61
31796709 2019
27
Impact of Somatosensory Input Deficiency on Subjective Visual Vertical Perception in Children With Reading Disorders. 61
31632338 2019
28
Double Trouble: Visual and Phonological Impairments in English Dyslexic Readers. 61
31920790 2019
29
Steady-State Pattern Electroretinogram and Frequency Doubling Technology in Adult Dyslexic Readers. 61
31849443 2019
30
Beyond genes: A systematic review of environmental risk factors in specific reading disorder. 61
29566979 2018
31
Interventions for children with dyslexia: A review on current intervention methods. 61
30350811 2018
32
Amygdala sub-regional functional connectivity predicts anxiety in children with reading disorder. 61
29143475 2018
33
Co-morbidities in Chinese children with attention deficit/hyperactivity disorder and reading disabilities. 61
29271537 2018
34
Randomized trial of iReadMore word reading training and brain stimulation in central alexia. 61
29912350 2018
35
Atypical predictive processing during visual statistical learning in children with developmental dyslexia: an event-related potential study. 61
29907920 2018
36
Sluggish dorsally-driven inhibition of return during orthographic processing in adults with dyslexia. 61
29453081 2018
37
Familial study of attentional and behavioural problems in children with Dyslexia and their first-degree relatives in Indian setting. 61
29500977 2018
38
Does the late positive component reflect successful reading acquisition? A longitudinal ERP study. 61
29159040 2018
39
Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. 61
29061089 2018
40
Recognizing Psychiatric Comorbidity With Reading Disorders. 61
29636707 2018
41
Combined Modality Intervention for ADHD With Comorbid Reading Disorders: A Proof of Concept Study. 61
27895238 2018
42
Altered Structural Connectivity of the Left Visual Thalamus in Developmental Dyslexia. 61
29153326 2017
43
Unfolding the genetic pathways of dyslexia in Asian population: A review. 61
28619243 2017
44
Neurobiological Bases of Reading Disorder Part II: The Importance of Developmental Considerations in Typical and Atypical Reading. 61
29276529 2017
45
Attitudes and knowledge of parents of preschool children about specific learning disabilities. 61
28953831 2017
46
Neural Noise Hypothesis of Developmental Dyslexia. 61
28400089 2017
47
Acquired spatial dyslexia. 61
26272419 2017
48
Comorbidity of Arithmetic and Reading Disorder. 61
26772796 2017
49
Neurobiological bases of reading disorder Part I: Etiological investigations. 61
28785303 2017
50
Dyslexia risk gene relates to representation of sound in the auditory brainstem. 61
28182973 2017

Variations for Reading Disorder

Expression for Reading Disorder

Search GEO for disease gene expression data for Reading Disorder.

Pathways for Reading Disorder

GO Terms for Reading Disorder

Biological processes related to Reading Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuron migration GO:0001764 9.13 KIAA0319 DNAAF4 DCDC2
2 nervous system development GO:0007399 9.02 ROBO1 NRSN1 KIAA0319 DNAAF4 DCDC2

Molecular functions related to Reading Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.6 TDP2 ROBO1 NRSN1 MRPL19 KIAA0319L KIAA0319

Sources for Reading Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....